NCT06757673Not yet recruiting
Effectiveness of Robot-Assisted Intervention and Sensory Integration Therapy in Enhancing Social-Emotional Skills in Children With Autism
Effectiveness of Robot-assisted Interaction Compared to Sensory Integration for Social Emotion Control in Autism Spectrum Disorder
Source: ClinicalTrials.gov · Last updated 9 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is designed to evaluate and compare the impact of robot-assisted intervention using a smart robot (Kebbi Air) and traditional sensory integration therapy on improving social-emotional skills in children diagnosed with autism spectrum disorder (ASD) or suspected ASD. The study will enroll children aged 4 to 6 years, who will be randomly assigned to one of two groups: the experimental group, which will participate in guided interactions with the smart robot, or the control group, which will receive sensory integration therapy tailored to enhance emotional and social functioning. The research aims to explore whether interactions with the robot, which are designed to simulate real-world social scenarios, can provide comparable or enhanced benefits compared to traditional sensory integration methods. Pre- and post-intervention assessments will be conducted over a 12-week period, using tools like the Achenbach System of Empirically Based Assessment (ASEBA) and the Sensory Processing Measure (SPM) to measure changes in emotional regulation, sensory processing abilities, and social engagement. The study hypothesizes that the robot-assisted intervention will offer a novel, engaging, and effective approach to supporting the developmental needs of children with ASD.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- First submitted
- 27 Dec 2024
- Start date
- 7 Jan 2025
- Primary completion date
- 31 Jan 2025
- Lead sponsor
- National Taiwan University Hospital
- Diseases
- Autism
- NCT number
- NCT06757673
What you commit to
- Study type: Interventional
- Planned participants: 12
- From 7 Jan 2025 to the primary completion date, 31 Jan 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any physical or psychological condition deemed by the investigators to interfere with the intervention or assessments.
Age
- Children younger than 4 years or older than 6 years.
Other
- Cognitive ability: DQ \< 70, as assessed by CDIIT, indicating limited learning potential.
- Social-emotional ability: DQ ≥ 85, as assessed by CDIIT, indicating normal emotional and social functioning.
Who the study is looking for
- Children aged 4-6 years, regardless of gender.
- Diagnosed with autism spectrum disorder (ASD) or suspected ASD.
- Cognitive ability: Developmental Quotient (DQ) ≥ 70, as assessed by the Comprehensive 4. Developmental Inventory for Infants and Toddlers (CDIIT).Social-emotional ability: DQ \< 85, as assessed by CDIIT, indicating challenges in emotional regulation and social skills.
- 5\. No significant physical or psychological conditions that could interfere with participation in the intervention.
Age in the registry: 4 years to 6 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.